Article Information
History
- January 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Thu Nguyen-Anh Tran1,
- Nathan Wikle2,
- Joseph Albert3,
- Haider Inam4,
- Emily Strong2,
- Karel Brinda5,6,
- Scott M Leighow4,
- Fuhan Yang1,
- Sajid Hossain7,
- Justin R Pritchard4,
- Philip Chan8,
- William P Hanage5,
- Ephraim M Hanks2 and
- Maciej F Boni1,*
- 1Center for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, University Park, PA
- 2Center for Infectious Disease Dynamics, Department of Statistics, Pennsylvania State University, University Park, PA
- 3Department of Physics, Pennsylvania State University, University Park, PA
- 4Center for Infectious Disease Dynamics, Department of Bioengineering, Pennsylvania State University, University Park, PA
- 5Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA
- 6Department of Biomedical Informatics, Harvard Medical School, Boston, MA
- 7Yale School of Medicine, Yale University, New Haven, CT
- 8Department of Medicine, Brown University, Providence, RI
- ↵*Manuscript Correspondence: Maciej F. Boni, Center for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, University Park, PA, tel +1 814 867 4651, email: mfb9{at}psu.edu
Posted January 15, 2021.
Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts
